Share Price and Basic Stock Data
Last Updated: February 6, 2026, 8:17 pm
| PEG Ratio | 10.31 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Colgate-Palmolive (India) Ltd, a prominent player in the personal care industry, reported a current price of ₹2,127 and a market capitalization of ₹57,939 Cr. The company has shown a steady revenue growth trajectory, with sales recorded at ₹5,226 Cr for the fiscal year ending March 2023, up from ₹5,100 Cr in the previous year. The trailing twelve months (TTM) revenue stood at ₹5,878 Cr, reflecting the company’s resilience in a competitive market. Quarterly sales fluctuated, with a notable increase in the September 2023 quarter, reaching ₹1,471 Cr, compared to ₹1,387 Cr in September 2022. This upward trend in sales indicates a robust market demand for Colgate’s product offerings, particularly in oral care, where the brand maintains a significant market share. The company’s strategic focus on innovation and marketing has likely contributed to this revenue growth, positioning it favorably against industry peers.
Profitability and Efficiency Metrics
Colgate-Palmolive (India) Ltd demonstrated impressive profitability metrics, with a net profit of ₹1,326 Cr and an operating profit margin (OPM) of 31%. The net profit margin stood at 23.78% for the fiscal year 2025, indicating a strong ability to convert sales into profits. The company reported an exceptional return on equity (ROE) of 81.2% and a return on capital employed (ROCE) of 105%, showcasing its efficient capital utilization and ability to generate high returns for shareholders. Operating profit for FY 2024 was recorded at ₹1,901 Cr, reflecting a growth trajectory from ₹1,566 Cr in FY 2022. The interest coverage ratio (ICR) stood at 485.39x, suggesting that the company is well-positioned to meet its interest obligations, thus maintaining financial stability. These profitability and efficiency metrics are significantly higher than typical sector averages, underscoring Colgate’s competitive advantage in the personal care market.
Balance Sheet Strength and Financial Ratios
Colgate-Palmolive (India) Ltd maintains a robust balance sheet, with total assets reported at ₹3,019 Cr for FY 2025. The company’s reserves stood at ₹1,555 Cr, and borrowings were minimal at ₹60 Cr, reflecting prudent financial management and low leverage. The current ratio of 1.38 indicates adequate liquidity to meet short-term obligations, while the quick ratio of 1.08 further supports the company’s financial health. The price-to-book value (P/BV) ratio was reported at 39.07x, suggesting that the market values the company significantly higher than its book value, indicative of strong investor confidence. Additionally, the asset turnover ratio of 1.94 demonstrates effective asset utilization in generating revenue. These financial ratios illustrate Colgate’s strong financial position, enabling it to pursue growth opportunities while managing risks effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Colgate-Palmolive (India) Ltd reflects a stable ownership structure, with promoters holding 51% of the shares. Foreign institutional investors (FIIs) represent 17.16% of the shareholding, down from a peak of 24.94% in September 2024, indicating a potential shift in investor sentiment. Domestic institutional investors (DIIs) have increased their stake to 11.95%, up from 7.55% in December 2022, showing growing confidence among local investors. The total number of shareholders rose to 3,32,409 by September 2025, indicating increasing retail participation. This diversified ownership structure provides stability and reflects investor confidence in the company’s long-term prospects, despite the fluctuations in FII holdings. The company’s consistent dividend payout, reported at ₹51.00 per share for FY 2025, further enhances its attractiveness to investors seeking income.
Outlook, Risks, and Final Insight
Looking ahead, Colgate-Palmolive (India) Ltd faces a favorable outlook driven by its strong brand recognition and market leadership in oral care. However, potential risks include rising raw material costs and increased competition from emerging brands, which could pressure margins. Additionally, a decline in FII interest may affect stock performance in the short term. The company’s focus on innovation and expansion into new product categories may mitigate these risks and sustain growth. With a solid financial foundation and strategic initiatives in place, Colgate is well-positioned to navigate challenges and capitalize on market opportunities. The combination of high profitability, efficient operations, and a stable balance sheet supports a bullish long-term outlook, provided the company maintains its competitive edge and addresses market dynamics effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,283 Cr. | 286 | 334/190 | 74.6 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 39.4 Cr. | 23.4 | 35.4/22.3 | 77.2 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 114 Cr. | 119 | 149/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 526 Cr. | 350 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 8,953 Cr. | 244 | 408/239 | 24.5 | 55.8 | 1.43 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 71,172.93 Cr | 1,885.90 | 54.08 | 112.70 | 0.85% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,291 | 1,351 | 1,324 | 1,471 | 1,396 | 1,490 | 1,497 | 1,619 | 1,462 | 1,463 | 1,434 | 1,520 | 1,486 |
| Expenses | 930 | 899 | 906 | 989 | 927 | 958 | 988 | 1,122 | 1,007 | 964 | 981 | 1,054 | 1,044 |
| Operating Profit | 361 | 452 | 418 | 482 | 468 | 532 | 508 | 497 | 454 | 498 | 453 | 465 | 442 |
| OPM % | 28% | 33% | 32% | 33% | 34% | 36% | 34% | 31% | 31% | 34% | 32% | 31% | 30% |
| Other Income | 10 | 18 | -5 | 21 | 18 | 23 | 23 | 76 | 20 | 19 | 18 | 15 | 31 |
| Interest | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 44 | 43 | 44 | 44 | 41 | 42 | 42 | 42 | 41 | 38 | 38 | 37 | 36 |
| Profit before tax | 327 | 426 | 369 | 458 | 443 | 511 | 489 | 530 | 433 | 478 | 432 | 442 | 436 |
| Tax % | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 26% | 25% | 26% | 26% | 26% | 26% |
| Net Profit | 243 | 316 | 274 | 340 | 330 | 380 | 364 | 395 | 323 | 355 | 321 | 328 | 324 |
| EPS in Rs | 8.94 | 11.63 | 10.06 | 12.50 | 12.14 | 13.96 | 13.38 | 14.52 | 11.87 | 13.05 | 11.79 | 12.04 | 11.91 |
Last Updated: February 7, 2026, 12:02 am
Below is a detailed analysis of the quarterly data for Colgate-Palmolive (India) Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 1,486.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,520.00 Cr. (Sep 2025) to 1,486.00 Cr., marking a decrease of 34.00 Cr..
- For Expenses, as of Dec 2025, the value is 1,044.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,054.00 Cr. (Sep 2025) to 1,044.00 Cr., marking a decrease of 10.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 442.00 Cr.. The value appears to be declining and may need further review. It has decreased from 465.00 Cr. (Sep 2025) to 442.00 Cr., marking a decrease of 23.00 Cr..
- For OPM %, as of Dec 2025, the value is 30.00%. The value appears to be declining and may need further review. It has decreased from 31.00% (Sep 2025) to 30.00%, marking a decrease of 1.00%.
- For Other Income, as of Dec 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Sep 2025) to 31.00 Cr., marking an increase of 16.00 Cr..
- For Interest, as of Dec 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 1.00 Cr..
- For Depreciation, as of Dec 2025, the value is 36.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 37.00 Cr. (Sep 2025) to 36.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 436.00 Cr.. The value appears to be declining and may need further review. It has decreased from 442.00 Cr. (Sep 2025) to 436.00 Cr., marking a decrease of 6.00 Cr..
- For Tax %, as of Dec 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 26.00%.
- For Net Profit, as of Dec 2025, the value is 324.00 Cr.. The value appears to be declining and may need further review. It has decreased from 328.00 Cr. (Sep 2025) to 324.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 11.91. The value appears to be declining and may need further review. It has decreased from 12.04 (Sep 2025) to 11.91, marking a decrease of 0.13.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:45 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,579 | 3,982 | 3,868 | 3,982 | 4,188 | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,040 | 5,878 |
| Expenses | 2,915 | 3,159 | 2,929 | 3,038 | 3,074 | 3,226 | 3,323 | 3,331 | 3,534 | 3,679 | 3,779 | 4,082 | 4,008 |
| Operating Profit | 664 | 823 | 940 | 944 | 1,114 | 1,236 | 1,202 | 1,510 | 1,566 | 1,547 | 1,901 | 1,958 | 1,870 |
| OPM % | 19% | 21% | 24% | 24% | 27% | 28% | 27% | 31% | 31% | 30% | 33% | 32% | 32% |
| Other Income | 115 | 32 | 7 | 41 | 26 | 68 | 49 | 30 | 26 | 42 | 57 | 139 | 72 |
| Interest | 0 | 0 | 0 | 0 | 0 | 2 | 10 | 7 | 6 | 5 | 5 | 4 | 4 |
| Depreciation | 51 | 75 | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 163 | 154 |
| Profit before tax | 728 | 780 | 835 | 851 | 983 | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,930 | 1,784 |
| Tax % | 26% | 28% | 30% | 32% | 32% | 32% | 22% | 23% | 23% | 26% | 26% | 26% | |
| Net Profit | 540 | 559 | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,437 | 1,326 |
| EPS in Rs | 19.85 | 20.55 | 21.37 | 21.23 | 24.76 | 28.52 | 30.02 | 38.07 | 39.65 | 38.50 | 48.67 | 52.83 | 48.75 |
| Dividend Payout % | 68% | 58% | 47% | 47% | 97% | 81% | 93% | 100% | 101% | 101% | 119% | 97% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 3.52% | 3.94% | -0.69% | 16.64% | 15.30% | 5.15% | 26.84% | 4.15% | -2.88% | 26.46% | 8.53% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.42% | -4.62% | 17.33% | -1.33% | -10.15% | 21.68% | -22.68% | -7.03% | 29.33% | -17.92% |
Colgate-Palmolive (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 6% |
| 3 Years: | 6% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 64% |
| 5 Years: | 73% |
| 3 Years: | 72% |
| Last Year: | 81% |
Last Updated: September 4, 2025, 9:30 pm
Balance Sheet
Last Updated: December 4, 2025, 12:51 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 586 | 757 | 1,004 | 1,247 | 1,497 | 1,420 | 1,567 | 1,139 | 1,707 | 1,689 | 1,847 | 1,637 | 1,555 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 83 | 102 | 91 | 83 | 69 | 72 | 61 | 60 |
| Other Liabilities | 894 | 932 | 972 | 1,037 | 1,039 | 1,097 | 908 | 1,637 | 1,084 | 1,098 | 1,250 | 1,293 | 1,535 |
| Total Liabilities | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,178 |
| Fixed Assets | 556 | 782 | 1,008 | 1,108 | 1,146 | 1,191 | 1,123 | 1,065 | 963 | 862 | 794 | 776 | 742 |
| CWIP | 142 | 141 | 78 | 167 | 159 | 199 | 190 | 145 | 122 | 114 | 110 | 38 | 29 |
| Investments | 37 | 37 | 31 | 31 | 31 | 31 | 19 | 19 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 759 | 742 | 885 | 1,005 | 1,228 | 1,206 | 1,272 | 1,666 | 1,817 | 1,907 | 2,292 | 2,204 | 2,406 |
| Total Assets | 1,493 | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,178 |
Below is a detailed analysis of the balance sheet data for Colgate-Palmolive (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,555.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,637.00 Cr. (Mar 2025) to 1,555.00 Cr., marking a decrease of 82.00 Cr..
- For Borrowings, as of Sep 2025, the value is 60.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 61.00 Cr. (Mar 2025) to 60.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,535.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,293.00 Cr. (Mar 2025) to 1,535.00 Cr., marking an increase of 242.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,178.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,019.00 Cr. (Mar 2025) to 3,178.00 Cr., marking an increase of 159.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 742.00 Cr.. The value appears to be declining and may need further review. It has decreased from 776.00 Cr. (Mar 2025) to 742.00 Cr., marking a decrease of 34.00 Cr..
- For CWIP, as of Sep 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 38.00 Cr. (Mar 2025) to 29.00 Cr., marking a decrease of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,406.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,204.00 Cr. (Mar 2025) to 2,406.00 Cr., marking an increase of 202.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,178.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,019.00 Cr. (Mar 2025) to 3,178.00 Cr., marking an increase of 159.00 Cr..
Notably, the Reserves (1,555.00 Cr.) exceed the Borrowings (60.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 664.00 | 823.00 | 940.00 | 944.00 | 1.00 | -82.00 | -101.00 | -90.00 | -82.00 | -68.00 | -71.00 | -60.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 | 14 |
| Inventory Days | 59 | 63 | 72 | 72 | 56 | 58 | 69 | 79 | 78 | 68 | 63 | 76 |
| Days Payable | 130 | 128 | 136 | 148 | 152 | 144 | 142 | 179 | 169 | 155 | 187 | 185 |
| Cash Conversion Cycle | -65 | -59 | -55 | -63 | -79 | -68 | -63 | -91 | -75 | -76 | -113 | -95 |
| Working Capital Days | -47 | -40 | -43 | -39 | -33 | -36 | -23 | -84 | -25 | -32 | -46 | -37 |
| ROCE % | 122% | 114% | 96% | 74% | 71% | 73% | 65% | 92% | 92% | 79% | 97% | 105% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Large & Midcap Fund | 1,903,662 | 1.06 | 395.14 | 700,000 | 2026-01-26 05:06:42 | 171.95% |
| Nippon India Multi Cap Fund | 1,692,665 | 0.7 | 351.35 | 500,473 | 2025-12-08 02:19:27 | 238.21% |
| SBI Midcap Fund | 1,500,000 | 1.34 | 311.36 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 1,300,000 | 0.64 | 269.84 | 1,100,000 | 2026-01-26 04:10:26 | 18.18% |
| HDFC Mid Cap Fund | 801,989 | 0.18 | 166.47 | N/A | N/A | N/A |
| SBI MNC Fund | 800,000 | 2.85 | 166.06 | N/A | N/A | N/A |
| SBI Dividend Yield Fund | 720,000 | 1.64 | 149.45 | N/A | N/A | N/A |
| Sundaram Mid Cap Fund | 670,277 | 1.05 | 139.13 | N/A | N/A | N/A |
| Nippon India Large Cap Fund | 600,677 | 0.25 | 124.68 | 497,594 | 2025-12-08 08:47:01 | 20.72% |
| SBI Consumption Opportunities Fund | 475,000 | 3.12 | 98.6 | 425,000 | 2026-01-26 00:48:41 | 11.76% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 52.83 | 48.67 | 38.50 | 39.65 | 38.07 |
| Diluted EPS (Rs.) | 52.83 | 48.67 | 38.50 | 39.65 | 38.07 |
| Cash EPS (Rs.) | 58.81 | 54.97 | 44.93 | 46.16 | 44.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 61.19 | 68.91 | 63.11 | 63.78 | 42.86 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 61.19 | 68.91 | 63.11 | 63.78 | 42.86 |
| Dividend / Share (Rs.) | 51.00 | 58.00 | 39.00 | 40.00 | 38.00 |
| Revenue From Operations / Share (Rs.) | 222.07 | 208.85 | 192.15 | 187.50 | 178.00 |
| PBDIT / Share (Rs.) | 77.09 | 72.70 | 58.85 | 58.54 | 56.62 |
| PBIT / Share (Rs.) | 71.11 | 66.39 | 52.42 | 52.02 | 49.91 |
| PBT / Share (Rs.) | 70.95 | 65.49 | 51.83 | 51.80 | 49.64 |
| Net Profit / Share (Rs.) | 52.82 | 48.67 | 38.50 | 39.65 | 38.07 |
| PBDIT Margin (%) | 34.71 | 34.80 | 30.62 | 31.22 | 31.80 |
| PBIT Margin (%) | 32.02 | 31.79 | 27.28 | 27.74 | 28.04 |
| PBT Margin (%) | 31.95 | 31.35 | 26.97 | 27.62 | 27.89 |
| Net Profit Margin (%) | 23.78 | 23.30 | 20.03 | 21.14 | 21.38 |
| Return on Networth / Equity (%) | 86.32 | 70.61 | 61.00 | 62.16 | 88.80 |
| Return on Capital Employeed (%) | 111.06 | 92.26 | 79.28 | 77.76 | 106.38 |
| Return On Assets (%) | 47.59 | 41.40 | 36.32 | 37.15 | 35.77 |
| Asset Turnover Ratio (%) | 1.94 | 1.87 | 1.81 | 1.76 | 1.76 |
| Current Ratio (X) | 1.38 | 1.54 | 1.43 | 1.37 | 0.84 |
| Quick Ratio (X) | 1.08 | 1.30 | 1.12 | 1.04 | 0.64 |
| Inventory Turnover Ratio (X) | 17.93 | 4.61 | 4.31 | 3.95 | 3.95 |
| Dividend Payout Ratio (NP) (%) | 113.57 | 88.35 | 101.29 | 47.92 | 141.85 |
| Dividend Payout Ratio (CP) (%) | 102.02 | 78.22 | 86.80 | 41.15 | 120.59 |
| Earning Retention Ratio (%) | -13.57 | 11.65 | -1.29 | 52.08 | -41.85 |
| Cash Earning Retention Ratio (%) | -2.02 | 21.78 | 13.20 | 58.85 | -20.59 |
| Interest Coverage Ratio (X) | 485.39 | 395.76 | 325.74 | 270.10 | 212.15 |
| Interest Coverage Ratio (Post Tax) (X) | 333.59 | 269.83 | 216.38 | 183.92 | 143.63 |
| Enterprise Value (Cr.) | 63942.79 | 72358.90 | 40063.94 | 41171.93 | 41551.30 |
| EV / Net Operating Revenue (X) | 10.59 | 12.74 | 7.67 | 8.07 | 8.58 |
| EV / EBITDA (X) | 30.49 | 36.59 | 25.03 | 25.86 | 26.98 |
| MarketCap / Net Operating Revenue (X) | 10.77 | 12.98 | 7.84 | 8.22 | 8.76 |
| Retention Ratios (%) | -13.57 | 11.64 | -1.29 | 52.07 | -41.85 |
| Price / BV (X) | 39.07 | 39.34 | 23.88 | 24.17 | 36.38 |
| Price / Net Operating Revenue (X) | 10.77 | 12.98 | 7.84 | 8.22 | 8.76 |
| EarningsYield | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 |
After reviewing the key financial ratios for Colgate-Palmolive (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 52.83. This value is within the healthy range. It has increased from 48.67 (Mar 24) to 52.83, marking an increase of 4.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 52.83. This value is within the healthy range. It has increased from 48.67 (Mar 24) to 52.83, marking an increase of 4.16.
- For Cash EPS (Rs.), as of Mar 25, the value is 58.81. This value is within the healthy range. It has increased from 54.97 (Mar 24) to 58.81, marking an increase of 3.84.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.19. It has decreased from 68.91 (Mar 24) to 61.19, marking a decrease of 7.72.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.19. It has decreased from 68.91 (Mar 24) to 61.19, marking a decrease of 7.72.
- For Dividend / Share (Rs.), as of Mar 25, the value is 51.00. This value exceeds the healthy maximum of 3. It has decreased from 58.00 (Mar 24) to 51.00, marking a decrease of 7.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 222.07. It has increased from 208.85 (Mar 24) to 222.07, marking an increase of 13.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 77.09. This value is within the healthy range. It has increased from 72.70 (Mar 24) to 77.09, marking an increase of 4.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 71.11. This value is within the healthy range. It has increased from 66.39 (Mar 24) to 71.11, marking an increase of 4.72.
- For PBT / Share (Rs.), as of Mar 25, the value is 70.95. This value is within the healthy range. It has increased from 65.49 (Mar 24) to 70.95, marking an increase of 5.46.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 52.82. This value is within the healthy range. It has increased from 48.67 (Mar 24) to 52.82, marking an increase of 4.15.
- For PBDIT Margin (%), as of Mar 25, the value is 34.71. This value is within the healthy range. It has decreased from 34.80 (Mar 24) to 34.71, marking a decrease of 0.09.
- For PBIT Margin (%), as of Mar 25, the value is 32.02. This value exceeds the healthy maximum of 20. It has increased from 31.79 (Mar 24) to 32.02, marking an increase of 0.23.
- For PBT Margin (%), as of Mar 25, the value is 31.95. This value is within the healthy range. It has increased from 31.35 (Mar 24) to 31.95, marking an increase of 0.60.
- For Net Profit Margin (%), as of Mar 25, the value is 23.78. This value exceeds the healthy maximum of 10. It has increased from 23.30 (Mar 24) to 23.78, marking an increase of 0.48.
- For Return on Networth / Equity (%), as of Mar 25, the value is 86.32. This value is within the healthy range. It has increased from 70.61 (Mar 24) to 86.32, marking an increase of 15.71.
- For Return on Capital Employeed (%), as of Mar 25, the value is 111.06. This value is within the healthy range. It has increased from 92.26 (Mar 24) to 111.06, marking an increase of 18.80.
- For Return On Assets (%), as of Mar 25, the value is 47.59. This value is within the healthy range. It has increased from 41.40 (Mar 24) to 47.59, marking an increase of 6.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.94. It has increased from 1.87 (Mar 24) to 1.94, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 24) to 1.38, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.30 (Mar 24) to 1.08, marking a decrease of 0.22.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 17.93. This value exceeds the healthy maximum of 8. It has increased from 4.61 (Mar 24) to 17.93, marking an increase of 13.32.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 113.57. This value exceeds the healthy maximum of 50. It has increased from 88.35 (Mar 24) to 113.57, marking an increase of 25.22.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 102.02. This value exceeds the healthy maximum of 50. It has increased from 78.22 (Mar 24) to 102.02, marking an increase of 23.80.
- For Earning Retention Ratio (%), as of Mar 25, the value is -13.57. This value is below the healthy minimum of 40. It has decreased from 11.65 (Mar 24) to -13.57, marking a decrease of 25.22.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -2.02. This value is below the healthy minimum of 40. It has decreased from 21.78 (Mar 24) to -2.02, marking a decrease of 23.80.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 485.39. This value is within the healthy range. It has increased from 395.76 (Mar 24) to 485.39, marking an increase of 89.63.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 333.59. This value is within the healthy range. It has increased from 269.83 (Mar 24) to 333.59, marking an increase of 63.76.
- For Enterprise Value (Cr.), as of Mar 25, the value is 63,942.79. It has decreased from 72,358.90 (Mar 24) to 63,942.79, marking a decrease of 8,416.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.59. This value exceeds the healthy maximum of 3. It has decreased from 12.74 (Mar 24) to 10.59, marking a decrease of 2.15.
- For EV / EBITDA (X), as of Mar 25, the value is 30.49. This value exceeds the healthy maximum of 15. It has decreased from 36.59 (Mar 24) to 30.49, marking a decrease of 6.10.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 10.77. This value exceeds the healthy maximum of 3. It has decreased from 12.98 (Mar 24) to 10.77, marking a decrease of 2.21.
- For Retention Ratios (%), as of Mar 25, the value is -13.57. This value is below the healthy minimum of 30. It has decreased from 11.64 (Mar 24) to -13.57, marking a decrease of 25.21.
- For Price / BV (X), as of Mar 25, the value is 39.07. This value exceeds the healthy maximum of 3. It has decreased from 39.34 (Mar 24) to 39.07, marking a decrease of 0.27.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 10.77. This value exceeds the healthy maximum of 3. It has decreased from 12.98 (Mar 24) to 10.77, marking a decrease of 2.21.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Colgate-Palmolive (India) Ltd:
- Net Profit Margin: 23.78%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 111.06% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 86.32% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 333.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 43.5 (Industry average Stock P/E: 54.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 23.78%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Colgate Research Centre, Main Street, Mumbai Maharashtra 400076 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mukul Deoras | Chairman |
| Ms. Prabha Narasimhan | Managing Director & CEO |
| Mr. M S Jacob | WholeTime Director & CFO |
| Mr. Surender Sharma | Whole Time Director |
| Mr. Sekhar Natarajan | Ind. Non-Executive Director |
| Ms. Sukanya Kripalu | Ind. Non-Executive Director |
| Ms. Gopika Pant | Ind. Non-Executive Director |
| Dr. Indu Bhushan | Ind. Non-Executive Director |
| Mr. Sanjay Gupta | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Colgate-Palmolive (India) Ltd?
Colgate-Palmolive (India) Ltd's intrinsic value (as of 06 February 2026) is ₹1754.94 which is 17.72% lower the current market price of ₹2,133.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹58,036 Cr. market cap, FY2025-2026 high/low of ₹2,747/2,029, reserves of ₹1,555 Cr, and liabilities of ₹3,178 Cr.
What is the Market Cap of Colgate-Palmolive (India) Ltd?
The Market Cap of Colgate-Palmolive (India) Ltd is 58,036 Cr..
What is the current Stock Price of Colgate-Palmolive (India) Ltd as on 06 February 2026?
The current stock price of Colgate-Palmolive (India) Ltd as on 06 February 2026 is ₹2,133.
What is the High / Low of Colgate-Palmolive (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Colgate-Palmolive (India) Ltd stocks is ₹2,747/2,029.
What is the Stock P/E of Colgate-Palmolive (India) Ltd?
The Stock P/E of Colgate-Palmolive (India) Ltd is 43.5.
What is the Book Value of Colgate-Palmolive (India) Ltd?
The Book Value of Colgate-Palmolive (India) Ltd is 58.2.
What is the Dividend Yield of Colgate-Palmolive (India) Ltd?
The Dividend Yield of Colgate-Palmolive (India) Ltd is 2.39 %.
What is the ROCE of Colgate-Palmolive (India) Ltd?
The ROCE of Colgate-Palmolive (India) Ltd is 105 %.
What is the ROE of Colgate-Palmolive (India) Ltd?
The ROE of Colgate-Palmolive (India) Ltd is 81.2 %.
What is the Face Value of Colgate-Palmolive (India) Ltd?
The Face Value of Colgate-Palmolive (India) Ltd is 1.00.